| Trial ID: | L2783 |
| Source ID: | NCT03102801
|
| Associated Drug: |
Humulin S
|
| Title: |
A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus With Hypoglycemia
|
| Interventions: |
DRUG: Humulin S
|
| Outcome Measures: |
Primary: Measurement of endothelial microparticles (composite number of CD105, CD106, CD142, CD54, CD62 & CD31) following hypoglycemic event, 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Hull
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER
|
| Start Date: |
2017-03-01
|
| Completion Date: |
2018-01-10
|
| Results First Posted: |
|
| Last Update Posted: |
2018-11-01
|
| Locations: |
Hull and east Yorkshire Hospitals NHS Trust, Hull, HU32RW, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT03102801
|
